3-(2-Furyl)-L-alanine

3-(2-Furyl)-L-alanine is an L-amino acid bearing a 2-furyl substituent on the side chain, providing an aromatic heterocycle that is routinely leveraged as a chemically distinctive building block in peptide and medicinal chemistry workflows. Its free amino and carboxylic acid functionality makes it a practical precursor for incorporation into synthetic sequences and for preparing derivatives used in structure-activity relationship studies. The heteroaromatic side chain also supports downstream analytical characterization and derivatization strategies where furan-containing motifs are advantageous.

1. Peptide Building Block

3-(2-Furyl)-L-alanine is used by peptide chemistry groups to introduce a furan-containing side chain into custom peptides, enabling systematic variation of aromatic character and heteroatom content along the peptide backbone. Researchers commonly employ this amino acid when designing peptide analogs for receptor-binding studies, protease-substrate mapping, or conformational/sequence dependence experiments where a nonstandard aromatic side chain is needed. Because the compound is an L-amino acid, it integrates cleanly into peptide assembly strategies that require stereochemically defined residues, supporting reliable sequence construction for downstream purification and characterization.

2. Medicinal Chemistry SAR Studies

3-(2-Furyl)-L-alanine is frequently selected by medicinal chemistry and chemical biology teams as a building block for peptidomimetic scaffolds and amino-acid-derived fragments used in structure-activity relationship (SAR) campaigns. The 2-furyl side chain provides a compact heteroaromatic motif that can modulate physicochemical properties and molecular recognition patterns in analog series, while remaining synthetically tractable for conversion into protected intermediates or coupling-ready derivatives during lead optimization. This makes the amino acid useful for preparing libraries of analogs intended for binding assays, off-target profiling, and property screening workflows where heteroaromatic substitution is a key variable.

3. Pharmaceutical Intermediate Synthesis

3-(2-Furyl)-L-alanine is also used as a starting material for the preparation of downstream pharmaceutical intermediates that retain the furan heterocycle for incorporation into larger drug-like structures. Industrial and development chemists rely on amino acid-derived intermediates to build complex heteroaromatic-containing fragments while maintaining the stereochemical integrity associated with L-amino acid starting points. In practice, the compound's amino acid functionality supports conversion into a variety of intermediate formats used in multi-step synthesis planning, including routes that require a defined chiral center adjacent to a heteroaromatic side chain.

1. High fat diet and GLP-1 drugs induce pancreatic injury in mice

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

4. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists